An overlooked mental health challenge faced by new mothers. A powerful new drug Zurzuvae could be critical in fighting back. It should have been an obvious match. Yet things may not turn out that way because of pharma industry’s pricing vagaries as well as the lack of conversation around the condition itself.
Related Posts
Low-quality drugs are posing a risk to India’s global image. Can Rajeev Raghuvanshi fix the faults?
Synopsis At a conference last year, India’s new drug controller general Rajeev Raghuvanshi, who was then the scientific director at…
India has a major health insurance headache
It is important for state-run health insurance to ensure more hospitals join to provide a safety net to the poor.
Debt-hobbled Glenmark is looking to boost earnings. Execution will be key to winning back investors.
Glenn Saldanha, managing director and CEO, Glenmark pharmaceuticals; image credit: Agencies Synopsis Coping with a tough US generics business and…
